A cancer patient has reportedly endured over 14 years of ineffective chemotherapy treatments, contrary to NHS guidelines advising that temozolomide should only be used for six months. This alarming revelation has prompted lawyers to suggest that this case may represent broader systemic issues within the healthcare system, with indications of at least 12 other patients possibly affected. University Hospitals Coventry and Warwickshire NHS Trust has initiated an internal review and acknowledged that the treatment was not based on established evidence, expressing regret for the patient's ordeal and the associated health risks from prolonged chemotherapy.
I cannot imagine the impact that this has had on him. I wish to apologise on behalf of the trust for your son going through unnecessary treatment.
Lawyers for the patient claim that long-term treatment with temozolomide risks secondary cancer, chronic liver problems and reinforces the fear of death.
The prolonged chemotherapy programme was only discovered when the consultant treating him, Prof Ian Brown, retired, and a new consultant confirmed the cycles were not needed.
This case is the 'tip of the iceberg,' highlighting potential systemic issues with patient care in the NHS.
Collection
[
|
...
]